Ischemic preconditioning enhances donor heart preservation

Transplantation

Volumn 62, Issue 1, 1996, Pages 17-22

  Karck, Matthias ^a   Rahmanian, Parwis ^a   Haverich, Axel ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART PROTECTION; HIGH ENERGY PHOSPHATE; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALLOPURINOL; ANIMALS; COLD; CORONARY CIRCULATION; CREATINE KINASE; ENERGY METABOLISM; GLUTATHIONE; HEART TRANSPLANTATION; INSULIN; ISCHEMIA; MALE; MYOCARDIUM; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RATS; RATS, WISTAR;

EID: 0029892668     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607150-00004     Document Type: Article

References (25)

1. Metha JL, Yang B, Kerensky RA, Conti CR. Potential therapeutic implications of the phenomenon of ischemic preconditioning of the myocardium: lessons from animal and catheterization laboratories. Am J Cardiol 1994; 74: 1270.
2. Murry CE, Jennings PB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124.
3. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133.
4. Iwamato T, Miura T, Adachi T, et al. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free radical scavengers in the rabbit. Circulation 1991; 83: 1015.
5. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with ischemic preconditioning. Circulation 1990; 82: 609.
6. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic and metabolic features. Circulation 1990; 82: 2044.
7. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993; 342: 276.
8. Nao BS, McClanahan TB, Groh MA, Schott RJ, Gallagher KP. The time limit of effective ischemic preconditioning in dogs [Abstract]. Circulation 1990; 82 (suppl III): 271.
9. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991; 260: H796.
10. Murry CE, Jennings RB, Reimer KA. Preconditioning myocardium for 5 min coronary occlusion infarct size limitation after 40 but not 180 minutes of sustained ischemia [Abstract]. J Mol Cell Cardiol 1986; 18 (suppl III): 49.
11. Neely JR, Liebermeister H, Battersby EJ, Moegen HE. Effect of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 1967; 212: 804.
12. Yamamoto F, Braimbridge MV, Hearse DJ. Calcium cardioplegia: the optimal calcium content for the St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg 1984; 87: 908.
13. Lowry O, Passonneau J. A flexible system for enzymatic analysis. London: Academic Press, 1972: 123.
14. Bergmeyer HU, ed. Methods in enzymatic analysis. London: Academic Press, 1974: 1777.
15. Kloner RA, Przyklenk K. Is preconditioning relevant to clinical medicine? In: Przyklenk K, Kloner RA, Yellon DM, eds. Ischemic preconditioning: the concept of endogenous cardioprotection. Boston: Kluver, 1994: 173.
16. Cave AC, Hearse DJ. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischemia. J Mol Cell Cardiol 1992; 24: 1113.
17. Illes RW, Wright JK, Inners-McBride K, Yang CJ, Tristan A. Ischemic preconditioning improves preservation with crystalloid cardioplegia. Ann Thorac Surg 1994; 58: 1481.
18. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913.
19. Karck M, Haverich A. Ischämische Präkonditionierung verbessert die Pumpfunktion isolierter Rattenherzen nach Globalischämie bei 4°C [Abstract]. Z Kardiol 1995; 84: 184.
20. Miura M, Adachi T, Ogawa T, Iwamoto T, Tsuchida A, Imura O. Myocardial infarct size limitation by preconditioning: its natural decay and "dose-response" relation [Abstract]. J Mol Cell Cardiol 1991; 23 (suppl II): 38.
21. 31phosphorus magnetic resonance spectroscopy [Abstract]. Clin Res 1989; 37: 255.
22. Volovsek A, Subramanian R, Reboussin D. Effects of duration of ischemia during preconditioning on myocardial function, enzyme release and energy production in the isolated working rat heart. J Mol Cell Cardiol 1992; 24: 1011.
23. 31Phosphorus NMR spectroscopy. J Thorac Cardiovasc Surg 1992; 104: 1356.
24. Okouchi Y, Shimizu K, Yamaguchi A, Kamada N. Effectiveness of modified University of Wisconsin solution for heart preservation as assessed in heterotopic rat heart transplant model. J Thorac Cardiovasc Surg 1990; 99: 1104.
25. Ko W, Zelano JA, Lazzaro R, et al. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation: a study of left ventricular pressure-volume relationship. J Thorac Cardiovasc Surg 1992; 103: 980.